Literature DB >> 32747494

The 'wait for symptoms' strategy in asymptomatic severe aortic stenosis.

José Alberto San Román1, Isidre Vilacosta2, Manuel J Antunes3, Bernard Iung4, Javier Lopez5, Hans-Joachim Schäfers6.   

Abstract

Calcific aortic stenosis is a prevalent and worrisome healthcare problem. The therapeutic approach in asymptomatic aortic stenosis is not well established. We argue that the natural history of this disease is based on old incomplete studies with many limitations. Likewise, studies suggesting that replacement, either surgical or percutaneous, improves prognosis in asymptomatic patients with severe aortic stenosis have important drawbacks and do not support this strategy as the treatment of choice. Despite the lack of evidence, some groups recommend early valve replacement in patients with severe asymptomatic aortic stenosis. There are five ongoing randomised trials which will shed light on this topic. Our conclusion is that unless a randomised study changes the evidence, valve replacement cannot be recommended in asymptomatic patients with severe aortic stenosis. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  aortic stenosis; valve disease surgery

Mesh:

Year:  2020        PMID: 32747494     DOI: 10.1136/heartjnl-2020-317323

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  3 in total

Review 1.  Moderate aortic stenosis: culprit or bystander?

Authors:  Varayini Pankayatselvan; Inbar Raber; David Playford; Simon Stewart; Geoff Strange; Jordan B Strom
Journal:  Open Heart       Date:  2022-01

2.  Uncovering the treatable burden of severe aortic stenosis in the UK.

Authors:  Geoffrey A Strange; Simon Stewart; Nick Curzen; Simon Ray; Simon Kendall; Peter Braidley; Keith Pearce; Renzo Pessotto; David Playford; Huon H Gray
Journal:  Open Heart       Date:  2022-01

3.  Counting the cost of premature mortality with progressively worse aortic stenosis in Australia: a clinical cohort study.

Authors:  Simon Stewart; Clifford Afoakwah; Yih-Kai Chan; Jordan B Strom; David Playford; Geoffrey A Strange
Journal:  Lancet Healthy Longev       Date:  2022-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.